Does VUTRISIRAN Cause Hypervolaemia? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Hypervolaemia have been filed in association with VUTRISIRAN (AMVUTTRA). This represents 1.1% of all adverse event reports for VUTRISIRAN.
15
Reports of Hypervolaemia with VUTRISIRAN
1.1%
of all VUTRISIRAN reports
0
Deaths
14
Hospitalizations
How Dangerous Is Hypervolaemia From VUTRISIRAN?
Of the 15 reports, 14 (93.3%) required hospitalization.
Is Hypervolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VUTRISIRAN. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does VUTRISIRAN Cause?
Death (244)
Hospitalisation (143)
Intentional dose omission (80)
Therapy interrupted (66)
Fall (65)
Fatigue (56)
Product dose omission issue (45)
Pain in extremity (43)
Dyspnoea (42)
Gait disturbance (42)
What Other Drugs Cause Hypervolaemia?
TREPROSTINIL (580)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (428)
AMBRISENTAN (205)
MACITENTAN (202)
FUROSEMIDE (139)
AMLODIPINE (122)
CYCLOPHOSPHAMIDE (118)
SACUBITRIL\VALSARTAN (115)
TACROLIMUS (100)
PREDNISONE (98)
Which VUTRISIRAN Alternatives Have Lower Hypervolaemia Risk?
VUTRISIRAN vs VX-950
VUTRISIRAN vs VYVANSE
VUTRISIRAN vs WARFARIN
VUTRISIRAN vs WATER
VUTRISIRAN vs WELLBUTRIN